Back to Search Start Over

Benefit-Risk Assessment for Angiotensin System Modulators among Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients

Authors :
Maxine Gossell-Williams
Source :
Scholars Academic Journal of Pharmacy. 9:232-233
Publication Year :
2020
Publisher :
SASPR Edu International Pvt. Ltd, 2020.

Subjects

Subjects :
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Renin–angiotensin system
Immunology
Medicine
Benefit risk assessment
General Medicine
business

Details

ISSN :
23204206 and 23479531
Volume :
9
Database :
OpenAIRE
Journal :
Scholars Academic Journal of Pharmacy
Accession number :
edsair.doi...........e19f59c188c142602e50c03d79dc5d57

Tools

Authors Abstract Subjects Details